Genedx Holdings Corp (WGS)

$40.77 +0.27 (0.67%)
Market Cap 1.19B
Revenue (ttm) 427.54M
Net Income (ttm) -21.02M
EPS (ttm) N/A
PE Ratio 40.84
Forward PE 46.28
Profit Margin -4.92%
Debt to Equity Ratio 0.16
Volume 2,105,900
Avg Vol 1,130,014
Day's Range N/A - N/A
Shares Out 29.29M
Stochastic %K 23%
Beta 2.06
Analysts Strong Sell
Price Target $85.89

Company Profile

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 888 729 1206
Fax: 201 421 2010
Address:
North Tower, 6th Floor 333 Ludlow Street, Stamford, United States
Unicorn2020
Unicorn2020 May. 8 at 5:16 PM
$WGS Just sold at $41. Took $12K profit and bought 5K shares $SRPT @ $19.95. I'm just too good. What can I say? Kakaka.
0 · Reply
Unicorn2020
Unicorn2020 May. 8 at 11:20 AM
$WGS With the same low float and temporarily hitting rock bottom, this could swiftly move higher like $PHOE right now.
0 · Reply
KINGKASHH
KINGKASHH May. 8 at 12:31 AM
$WGS glad I sold this at $131. Bought in at $7
0 · Reply
SuperGreenToday
SuperGreenToday May. 7 at 10:09 PM
$WGS Share Price: $40.53 Contract Selected: May 29, 2026 $40 Calls Buy Zone: $2.38 – $2.94 Target Zone: $3.80 – $4.64 Potential Upside: 51% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PatrickandFrankie
PatrickandFrankie May. 7 at 9:19 PM
$WGS not too bad considering it was a risk off day to say the least! I think this bodes well for more recovery tomorrow that haircut was way overdone imho
0 · Reply
BB_88_
BB_88_ May. 7 at 8:08 PM
$WGS almost bought this at 33 but cold feet - strong movement today
0 · Reply
Unicorn2020
Unicorn2020 May. 7 at 7:59 PM
$RIOT Glad I bought some back at $19. This stock looks ready to make a move toward $27. I was heavily invested in $WULF, so I sold part of my RIOT position to grab the $WGS dip at $37 after the massive drop from $160.
0 · Reply
cubie
cubie May. 7 at 7:50 PM
$SHAK $ZTS $PRIM $WGS holy sht, congrats giddy bears😑. $PLNT earnings can be dangerous 😅😳
1 · Reply
Tradebub
Tradebub May. 7 at 6:48 PM
$WGS
0 · Reply
Markus_V
Markus_V May. 7 at 6:48 PM
$WGS We have WinGS :-D
0 · Reply
Latest News on WGS
Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

May 7, 2026, 9:30 AM EDT - 1 day ago

Barrack, Rodos & Bacine Investigates GeneDx Holdings Corp. (NASDAQ: WGS) For Possible Securities Fraud

GeneDX Holdings Investigated for Possible Securities Fraud; Investors Should Contact Block & Leviton to Recover Losses

May 6, 2026, 4:00 PM EDT - 2 days ago

GeneDX Holdings Investigated for Possible Securities Fraud; Investors Should Contact Block & Leviton to Recover Losses

WGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm's Investigation

May 5, 2026, 6:11 PM EDT - 3 days ago

WGS: GeneDX Shares Plummet Over 45%; Investors Should Contact Block & Leviton to Potentially Recover Money Through The Firm's Investigation

GeneDx price target lowered to $85 from $153 at Craig-Hallum

2026-05-05T12:38:23.000Z - 3 days ago

GeneDx price target lowered to $85 from $153 at Craig-Hallum

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

May 5, 2026, 8:09 AM EDT - 3 days ago

GeneDx Holdings Corp. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

GeneDx price target lowered to $55 from $60 at TD Cowen

2026-05-05T12:02:38.000Z - 3 days ago

GeneDx price target lowered to $55 from $60 at TD Cowen

GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks

2026-05-05T11:43:37.000Z - 3 days ago

GeneDx price target lowered to $90 from $170 at BTIG, removed from Top Picks

GeneDx price target lowered to $70 from $100 at Guggenheim

2026-05-05T11:27:49.000Z - 3 days ago

GeneDx price target lowered to $70 from $100 at Guggenheim

GeneDx price target lowered to $75 from $155 at Wells Fargo

2026-05-05T10:25:04.000Z - 3 days ago

GeneDx price target lowered to $75 from $155 at Wells Fargo

GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year

2026-05-04T20:32:20.000Z - 4 days ago

GeneDx reports Q1 adjusted loss ($8.2M) vs. ($9.2M) last year

GeneDx Holdings Earnings Call Transcript: Q1 2026

May 4, 2026, 4:30 PM EDT - 4 days ago

GeneDx Holdings Earnings Call Transcript: Q1 2026

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

May 4, 2026, 4:05 PM EDT - 4 days ago

GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook

GeneDx price target raised to $100 from $70 at Canaccord

2026-04-20T13:59:20.000Z - 18 days ago

GeneDx price target raised to $100 from $70 at Canaccord

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

Apr 13, 2026, 4:05 PM EDT - 25 days ago

GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026

Cathie Wood Buys the Dip in GeneDx (WGS); Wall Street Sees 142% Upside

2026-04-10T04:42:30.000Z - 4 weeks ago

Cathie Wood Buys the Dip in GeneDx (WGS); Wall Street Sees 142% Upside

ARCT ARKG ARKK BWXT SRTA

GeneDx price target lowered to $100 from $170 at Guggenheim

2026-03-30T11:51:54.000Z - 5 weeks ago

GeneDx price target lowered to $100 from $170 at Guggenheim

GeneDx falls after Natera launches sequencing assay for rare diseases

2026-03-12T13:11:31.000Z - 2 months ago

GeneDx falls after Natera launches sequencing assay for rare diseases

NTRA

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

Mar 11, 2026, 5:00 PM EDT - 2 months ago

Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 11, 2026, 3:00 PM EDT - 2 months ago

GeneDx Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

Mar 10, 2026, 8:30 AM EDT - 2 months ago

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

Mar 9, 2026, 8:30 AM EDT - 2 months ago

GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Feb 25, 2026, 8:03 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES GENEDX HOLDINGS CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

GeneDx to Participate in Upcoming Investor Conferences

Feb 25, 2026, 8:30 AM EST - 2 months ago

GeneDx to Participate in Upcoming Investor Conferences

GeneDx Holdings Earnings Call Transcript: Q4 2025

Feb 23, 2026, 8:30 AM EST - 2 months ago

GeneDx Holdings Earnings Call Transcript: Q4 2025

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 8:07 AM EST - 2 months ago

INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

Feb 23, 2026, 6:30 AM EST - 2 months ago

GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

Feb 11, 2026, 9:05 AM EST - 3 months ago

TIME Names GeneDx CEO Katherine Stueland to the 2026 TIME100 Health List of the World's Most Influential Leaders in Health

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Feb 3, 2026, 8:00 AM EST - 3 months ago

GeneDx to Report Fourth Quarter 2025 Financial Results on Monday, February 23, 2026

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

Jan 15, 2026, 11:24 AM EST - 4 months ago

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 6:00 PM EST - 4 months ago

GeneDx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference

Why is GeneDx stock crashing on Monday?

Jan 12, 2026, 3:03 PM EST - 4 months ago

Why is GeneDx stock crashing on Monday?

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

Jan 12, 2026, 7:30 AM EST - 4 months ago

GeneDx Announces Preliminary 2025 Financial Results and Provides 2026 Guidance

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

Jan 8, 2026, 8:30 AM EST - 4 months ago

GeneDx and Komodo Health Partner to Build the World's Most Complete Longitudinal Rare Disease Dataset

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

Jan 7, 2026, 8:30 AM EST - 4 months ago

GeneDx Announces GenomeDx Prenatal™, Expanding Industry-Leading Genomic Diagnosis Into Prenatal Care

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

Jan 6, 2026, 8:30 AM EST - 4 months ago

GeneDx Appoints Dr. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

Jan 5, 2026, 8:30 AM EST - 4 months ago

GeneDx Leads Rare Disease Genomics with Unmatched Research and Clinical Impact in 2025

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

Dec 30, 2025, 8:00 AM EST - 4 months ago

GeneDx to Present at the J.P. Morgan 2026 Healthcare Conference

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Dec 15, 2025, 8:30 AM EST - 5 months ago

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

Eight stock picks to play one of the healthiest corners of the market

Dec 11, 2025, 10:37 AM EST - 5 months ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM MASI NTRA PODD UNH

GeneDx Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 3, 2025, 1:30 PM EST - 5 months ago

GeneDx Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

GeneDx Holdings Transcript: Jefferies London Healthcare Conference 2025

Nov 19, 2025, 6:00 AM EST - 6 months ago

GeneDx Holdings Transcript: Jefferies London Healthcare Conference 2025

GeneDx Holdings Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 2:00 PM EST - 6 months ago

GeneDx Holdings Transcript: Stifel 2025 Healthcare Conference

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

Nov 6, 2025, 8:00 AM EST - 6 months ago

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

GeneDx Holdings Earnings Call Transcript: Q3 2025

Oct 28, 2025, 8:30 AM EDT - 6 months ago

GeneDx Holdings Earnings Call Transcript: Q3 2025

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

Oct 28, 2025, 6:30 AM EDT - 6 months ago

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

Oct 27, 2025, 8:00 AM EDT - 6 months ago

GeneDx Holdings Corp. (NASDAQ: WGS) Investor Reminder: Schubert Jonckheer Investigating Possible False Claims

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

Oct 22, 2025, 8:00 AM EDT - 7 months ago

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

Oct 20, 2025, 8:00 AM EDT - 7 months ago

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

Oct 15, 2025, 3:30 PM EDT - 7 months ago

GeneDX CEO Katherine Stueland on how the company is using AI to save lives

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Oct 15, 2025, 11:45 AM EDT - 7 months ago

GeneDX CEO Katherine Stueland on if the cuts at NIH impact the company

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Oct 15, 2025, 9:15 AM EDT - 7 months ago

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

ILMN

How GeneDX CEO Katherine Stueland is using AI to save lives

Oct 14, 2025, 3:17 PM EDT - 7 months ago

How GeneDX CEO Katherine Stueland is using AI to save lives

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

Oct 14, 2025, 8:00 AM EDT - 7 months ago

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

Oct 13, 2025, 8:00 AM EDT - 7 months ago

GeneDx to Partner with Florida's Sunshine Genetics Network, Launching Nation's First State-Backed Genomic Newborn Screening Program

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

Oct 9, 2025, 8:00 AM EDT - 7 months ago

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

Oct 8, 2025, 8:00 AM EDT - 7 months ago

GeneDx to Showcase Pioneering Research Findings at American Society of Human Genetics (ASHG) Annual Meeting

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

Oct 7, 2025, 8:00 AM EDT - 7 months ago

GeneDx to Report Third Quarter 2025 Financial Results on Tuesday, October 28, 2025

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

Oct 1, 2025, 4:01 PM EDT - 7 months ago

GeneDx Announces First U.S. National Genomic Newborn Screening Initiative Launched with $14.4 Million NIH Award

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

Sep 30, 2025, 8:00 AM EDT - 7 months ago

GeneDx Appoints Lisa Gurry as Chief Business Officer to Unlock Data and Information Growth

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

Sep 25, 2025, 8:00 AM EDT - 8 months ago

GeneDx Infinity™ Pioneers a New Era of Genetic Medicine with its Introduction at the American Academy of Pediatrics National Conference

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

Sep 18, 2025, 8:00 AM EDT - 8 months ago

GeneDx Appoints Visionary AI and Precision Medicine Leader Dr. Thomas Fuchs to Board of Directors

GeneDx Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 8, 2025, 8:30 AM EDT - 8 months ago

GeneDx Holdings Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

GeneDx Holdings Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Sep 4, 2025, 2:15 PM EDT - 8 months ago

GeneDx Holdings Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Seer Appoints Isaac Ro to its Board of Directors

Sep 2, 2025, 7:00 AM EDT - 8 months ago

Seer Appoints Isaac Ro to its Board of Directors

SEER

Unicorn2020
Unicorn2020 May. 8 at 5:16 PM
$WGS Just sold at $41. Took $12K profit and bought 5K shares $SRPT @ $19.95. I'm just too good. What can I say? Kakaka.
0 · Reply
Unicorn2020
Unicorn2020 May. 8 at 11:20 AM
$WGS With the same low float and temporarily hitting rock bottom, this could swiftly move higher like $PHOE right now.
0 · Reply
KINGKASHH
KINGKASHH May. 8 at 12:31 AM
$WGS glad I sold this at $131. Bought in at $7
0 · Reply
SuperGreenToday
SuperGreenToday May. 7 at 10:09 PM
$WGS Share Price: $40.53 Contract Selected: May 29, 2026 $40 Calls Buy Zone: $2.38 – $2.94 Target Zone: $3.80 – $4.64 Potential Upside: 51% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
PatrickandFrankie
PatrickandFrankie May. 7 at 9:19 PM
$WGS not too bad considering it was a risk off day to say the least! I think this bodes well for more recovery tomorrow that haircut was way overdone imho
0 · Reply
BB_88_
BB_88_ May. 7 at 8:08 PM
$WGS almost bought this at 33 but cold feet - strong movement today
0 · Reply
Unicorn2020
Unicorn2020 May. 7 at 7:59 PM
$RIOT Glad I bought some back at $19. This stock looks ready to make a move toward $27. I was heavily invested in $WULF, so I sold part of my RIOT position to grab the $WGS dip at $37 after the massive drop from $160.
0 · Reply
cubie
cubie May. 7 at 7:50 PM
$SHAK $ZTS $PRIM $WGS holy sht, congrats giddy bears😑. $PLNT earnings can be dangerous 😅😳
1 · Reply
Tradebub
Tradebub May. 7 at 6:48 PM
$WGS
0 · Reply
Markus_V
Markus_V May. 7 at 6:48 PM
$WGS We have WinGS :-D
0 · Reply
BB_88_
BB_88_ May. 7 at 6:42 PM
$WGS in again short 1k 39.955
1 · Reply
GRANT_Mcmillin
GRANT_Mcmillin May. 7 at 6:39 PM
$WGS so close to $40
0 · Reply
BB_88_
BB_88_ May. 7 at 6:30 PM
$WGS short 1k 39.88 tight stop
0 · Reply
GRANT_Mcmillin
GRANT_Mcmillin May. 7 at 6:12 PM
$FSLY yall will start to recover like $WGS is today
0 · Reply
PencilNeckGeek
PencilNeckGeek May. 7 at 6:03 PM
$WGS Come on, just give me $50. I'm not too greedy
1 · Reply
GRANT_Mcmillin
GRANT_Mcmillin May. 7 at 6:00 PM
$WGS looks like we might see $40
0 · Reply
PencilNeckGeek
PencilNeckGeek May. 7 at 2:38 PM
$WGS Would have been nice to see $40S today
2 · Reply
Unicorn2020
Unicorn2020 May. 7 at 2:20 PM
$WGS Bought 3K shares for the 1st time @ $37. Long. Will add more if it goes down to $25 or lower.
0 · Reply
PencilNeckGeek
PencilNeckGeek May. 7 at 2:14 PM
$WGS Hopefully it holds gains but I'm sceptical
0 · Reply
PencilNeckGeek
PencilNeckGeek May. 7 at 2:09 PM
$WGS I would be ecstatic with $50
0 · Reply
bc4
bc4 May. 7 at 1:58 PM
$WGS congrat everyone!
0 · Reply
cashstashh
cashstashh May. 7 at 1:48 PM
$WGS added few more to fuel the momentum (and to steal from shorts) . Lol 😛
0 · Reply